ArticleImmuno-oncology technology2022

Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments.

S M Castenmiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.